A different starting line for allergic march: food protein-induced allergic proctocolitis

Basit Öğe Kaydı
dc.contributor.authorBahceci, Semiha
dc.contributor.authorToz, Pinar Kuyum
dc.contributor.authorCelik, Figen Celebi
dc.contributor.authorCan, Demet
dc.date.accessioned2024-03-09T18:48:43Z
dc.date.available2024-03-09T18:48:43Z
dc.date.issued2023
dc.departmentİzmir Bakırçay Üniversitesien_US
dc.description.abstractObjective: The aim of this study is to investigate the long-term prognosis of food protein-induced allergic proctocolitis (FPIAP) patients, the risk of developing both allergic and gastrointestinal diseases, and to evaluate whether it leads to allergic march. Methods: A total of 149 children who were diagnosed with FPIAP and developed tolerance at least 5 years prior to the study and 41 children (with no history of food allergy) as a control group were enrolled. Both groups were re-evaluated for allergic diseases as well as gastrointestinal disorders. Results: The mean age of diagnosis for the FPIAP group was 4.2 +/- 3.0 months, while the mean age of tolerance was 13.9 +/- 7.7 months. The mean age of both FPIAP and control groups at the last visit was 101.6 +/- 24.4 and 96.3 +/- 24.1 months, respectively (P = 0.213). At the final evaluation of both groups, the comorbid allergic disease was significantly higher in the FPIAP group (P < 0.001). There was no significant difference between the two groups in terms of functional gastrointestinal disorders (FGIDs), eosinophilic gastrointestinal diseases, and inflammatory bowel disease (P = 0.198, 0.579, and 0.579, respectively). In the FPIAP group, the allergic disease was significantly higher at the final visit in patients with comorbid allergic disease at diagnosis (P < 0.001). In the FPIAP group, FGID was significantly higher in the group that developed allergic diseases in the future, compared to the group that did not develop allergic diseases in the future (P = 0.034). The proportion of both FGID and allergic diseases was significantly higher in subjects that developed tolerance at >18 months, compared to subjects that developed tolerance at =18 months (P < 0.001 and < 0.001, respectively). Conclusions: Patients with FPIAP may develop allergic diseases as well as FGID in the long term. (c) 2023 Codon Publications. Published by Codon Publications.en_US
dc.identifier.doi10.15586/aei.v51i4.872
dc.identifier.endpage45en_US
dc.identifier.issn0301-0546
dc.identifier.issn1578-1267
dc.identifier.issue4en_US
dc.identifier.pmid37422778en_US
dc.identifier.scopus2-s2.0-85164172709en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage40en_US
dc.identifier.urihttps://doi.org/10.15586/aei.v51i4.872
dc.identifier.urihttps://hdl.handle.net/20.500.14034/1436
dc.identifier.volume51en_US
dc.identifier.wosWOS:001026540700005en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherCodon Publicationsen_US
dc.relation.ispartofAllergologia Et Immunopathologiaen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAllergic March; Food Protein-Induced Allergic Proctocolitis; Functional Gastroin-Testinal Disorders; Inflammatory Bowel Disease; Prognosisen_US
dc.titleA different starting line for allergic march: food protein-induced allergic proctocolitisen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
1436.pdf
Boyut:
341.38 KB
Biçim:
Adobe Portable Document Format
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu